Sep 22, 2026 08:35AM
Sep 2, 2026 07:32AM
Aug 20, 2026 09:30AM
Jul 2, 2026 07:34AM
Jun 29, 2026 08:45AM
Jun 17, 2026 08:16AM
Jun 15, 2026 08:05AM Polyrizon initiates human study for NASARIX allergy blocker
Jun 10, 2026 07:47AM
Jun 8, 2026 09:31AM
May 13, 2026 09:25AM
May 4, 2026 08:45AM
Apr 27, 2026 09:29AM
Apr 7, 2026 08:10AM
Mar 26, 2026 09:24AM Polyrizon reports $17.5 million cash position, advances nasal drug programs
Mar 10, 2026 07:56AM
Feb 26, 2026 08:13AM
Feb 19, 2026 04:15PM
Feb 10, 2026 06:55AM
Feb 9, 2026 08:00AM
Feb 6, 2026 08:02AM
Feb 6, 2026 07:57AM Polyrizon partners with Clearmind to develop intranasal MEAI formulation
Jan 22, 2026 09:25AM
Jan 13, 2026 08:39AM
Jan 8, 2026 08:46AM
Jan 5, 2026 09:07AM
Jan 2, 2026 08:32AM
Dec 29, 2025 07:20AM
Dec 11, 2025 08:16AM Polyrizon reports positive permeation data for intranasal naloxone hydrogel
Dec 8, 2025 08:56AM
Dec 3, 2025 09:29AM
Dec 2, 2025 07:55AM
Nov 7, 2025 04:18PM
Nov 6, 2025 08:55AM
Oct 6, 2025 08:21AM
Sep 19, 2025 08:15AM Polyrizon submits FDA pre-submission package for PL-14 allergy blocker
Sep 12, 2025 07:26AM
Jul 22, 2025 08:32AM
Jul 15, 2025 07:55AM
Jun 12, 2025 07:32AM
May 23, 2025 04:17PM
May 13, 2025 07:45AM
Apr 25, 2025 07:37AM Polyrizon Ltd (PLRZ) Reports Successful Safety Study of a Formulation of PL-14 Allergy Blocker in Human Nasal Tissue Model
Apr 2, 2025 09:06AM
Apr 1, 2025 04:09PM
Mar 31, 2025 09:33AM
Mar 27, 2025 08:25AM
Mar 25, 2025 04:04PM
Mar 19, 2025 07:37AM
Mar 14, 2025 08:36AM Polyrizon (PLRZ) signs LOI with psychedelic therapeutics company to develop novel treatments
Mar 13, 2025 07:51AM

466,906 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All